Stock Price
24.42
Daily Change
0.06 0.25%
Monthly
-3.86%
Yearly
3.21%
Q2 Forecast
23.85

Galapagos reported EUR12.56M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
argenx SE USD 42.7M 4.3M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Incyte USD 30.75M 3.97M Dec/2025
Merck EUR 27M 10M Sep/2025
Sanofi EUR 33M 81M Dec/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025